Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus

Springer Science and Business Media LLC - Tập 21 Số 2 - Trang 195-214 - 2010
Mitsuru Saito1, Keishi Marumo1
1Department of Orthopaedic Surgery, Jikei University School of Medicine, Tokyo,, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Seeman E, Delmas PD (2006) Bone quality—the material and structural basis of bone strength and fragility. N Engl J Med 354:2250–2261

Takahashi M, Oikawa M, Nagano A (2000) Effect of age and menopause on serum concentrations of pentosidine, an advanced glycation end product. J Gerontol A Biol Sci Med Sci 55:M137–M140

Shiraki M, Kuroda T, Tanaka S et al (2008) Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures. J Bone Miner Metab 26:93–100

Shiraki M, Urano T, Kuroda T et al (2008) The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fracture. J Bone Miner Metab 26:595–602

Leboff MS, Narweker R, LaCroix A et al (2009) Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab 94:1207–1213

van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM et al (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 35:2033–2041

McLean RR, Jacques PF, Selhub J et al (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042–2049

Blouin S, Thaler HW, Korninger C et al (2009) Bone matrix quality and plasma homocysteine levels. Bone 44:959–964

Saito M, Fujii K, Marumo K (2006) Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 79:160–168

Gineyts E, Munoz F. Bertholon C et al (2009) Urinary levels of pentosidine and risk of fracture in post menopausal women: the OFELY study. Osteoporosis Int. doi: 10.1007/s00198-009-0939-5

Yamamoto M, Yamaguchi T, Yamauchi M et al (2008) Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 93:1013–1019

Schwartz AV, Garnero P, Hillier TA et al (2009) Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab 94:2380–2386

Lin AC, Goh MC (2002) Investigating the ultrastructure of fibrous long spacing collagen by parallel atomic force and transmission electron microscopy. Proteins 49:378–384

Robins SP, Bailey AJ (1977) The chemistry of the collagen cross-links. Characterization of the products of reduction of skin, tendon and bone with sodium cyanoborohydride. Biochem J 163:339–346

Uzawa K, Grzesik WJ, Nishiura T et al (1999) Differential expression of human lysyl hydroxylase genes, lysine hydroxylation, and cross-linking of type I collagen during osteoblastic differentiation in vitro. J Bone Miner Res 14:1272–1280

Saito M, Soshi S, Tanaka T, Fujii K (2004) Intensity-related differences in collagen post-traslational modification in MC3T3–E1 osteoblasts after exposure to low and high intensity pulsed ultrasound. Bone 35:644–655

Bank RA, Robins SP, Wijmenga C et al (1999) Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc Natl Acad Sci U S A 96:1054–1058

Saito M, Marumo K, Fujii K et al (1997) Single column high-performance liquid chromatographic-fluorescence detection of immature, mature and senescent cross-links of collagen. Anal Biochem 253:26–32

Marumo K, Saito M, Yamagishi M, Fujii K (2005) The “ligamentization” process in human anterior cruciate ligament reconstruction with autogenous patellar and hamstring tendons. Am J Sports Med 33:1166–1173

Yamauchi M, Katz EP (1993) The post-translational chemistry and molecular packing of mineralizing tendon collagens. Connect Tissue Res 29:81–98

Fujii K, Yamagishi T, Nagafuchi T et al (1994) Biochemical properties of collagen from ligaments and periarticular tendons of the human knee. Knee Surg Sports Traumatol Arthrosc 2:229–233

Yamauchi M, Katz EP, Mechanic GL (1986) Intermolecular cross-linking and stereospecific molecular packing in type I collagen fibrils of the periodontal ligament. Biochemistry 25:4907–4913

Yamauchi M, Woodley DT, Mechanic GL (1988) Aging and cross-linking of skin collagen. Biochem Biophys Res Commun 152:898–903

Yamauchi M, Shiiba M (2008) Lysine hydroxylation and cross-linking of collagen. Methods Mol Biol 446:95–108

Yeowell HN, Walker LC (1999) Tissue specificity of a new splice form of the human lysyl hydroxylase 2 gene. Matrix Biol 18:179–187

Yeowell HN, Walker LC (2000) Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI. Mol Genet Metab 71:212–224

Pornprasertsuk S, Duarte WR, Mochida Y et al (2005) Overexpression of lysyl hydroxylase-2b leads to defective collagen fibrillogenesis and matrix mineralization. J Bone Miner Res 20:81–87

Bank RA, Bayliss MT, Lafeber FP et al (1998) Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage. Biochem J 330:345–351

Eyre DR, Dickson IR, Ness KV (1988) Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues. Biochem J 252:495–500

Saito M, Soshi S, Fujii K (2003) Effect of hyper- and microgravity on collagen post-translational controls of MC3T3–E1 osteoblasts. J Bone Miner Res 18:1695–1705

Paschalis EP, Verdelis K, Doty SB, Boskey AL et al (2001) Spectroscopic characterization of collagen cross-links in bone. J Bone Miner Res 16:1821–1828

Eyre DR, Paz A, Gallop PM (1984) Cross-linking in collagen and elastin. Ann Rev Biochem 53:717–748

Kuboki Y, Kudo A, Mizuno M et al (1992) Time-dependent changes of collagen cross-links and their precursors in the culture of osteogenic cells. Calcif Tissue Int 50:473–480

Atsawasuwan P, Mochida Y, Parisuthiman D et al (2005) Expression of lysyl oxidase isoforms in MC3T3–E1 osteoblastic cells. Biochem Biophys Res Commun 327:1042–1046

Nagaoka H, Mochida Y, Atsawasuwan P et al (2008) 1,25(OH)2D3 regulates collagen quality in an osteoblastic cell culture system. Biochem Biophys Res Commun 377:674–678

Bird TA, Levene CI (1982) Lysyl oxidase: evidence that pyridoxal phosphate is a co-factor. Biochem Biophys Res Commun 108:1172–1180

Wang SX, Mure M, Medzihradszky KF et al (1996) A crosslinked cofactor in lysyl oxidase: redox function for amino acid side chains. Science 273:1078–1084

Fujii K, Kajiwara T, Kurosu H (1979) Effect of vitamin B6 deficiency on the crosslink formation of collagen. FEBS Lett 97:193–195

Feres-Filho EJ, Choi YJ, Han X et al (1995) Pre- and post-translational regulation of lysyl oxidase by transforming growth factor-beta 1 in osteoblastic MC3T3–E1 cells. J Biol Chem 270:30797–30803

Hong HH, Uzel MI, Duan C et al (1999) Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva. Lab Invest 79:1655–1667

Reiser K, Summers P, Medrano JF et al (1996) Effects of elevated circulating IGF-1 on the extracellular matrix in high-growth C57BL/6J mice. Am J Physiol 271:R696–R703

Ozasa H, Tominaga T, Nishimura T et al (1981) Lysyl oxidase activity in the mouse uterine cervix is physiologically regulated by estrogen. Endocrinology 109:618–621

Sanada H, Shikata J, Hamamoto H (1978) Changes in collagen cross-linking and lysyl oxidase by estrogen. Biochim Biophys Acta 541:408–413

Raposo B, Rodriguez C, Martinez-Gonzalez J et al (2004) High levels of homocysteine inhibit lysyl oxidase (LOX) and down regulate LOX expression in vascular endothelial cells. Atherosclerosis 177:1–8

Liu G, Nellaiappan K, Kagan HM (1997) Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J Biol Chem 272:32370–32377

Kang HA, Trelstad RL (1973) A collagen defect in homocystinuria. J Clin Invest 52:2571–2578

Feres-Filho EJ, Menassa GB, Trackman PC (1996) Regulation of lysyl oxidase by basic fibroblast growth factor in osteoblastic MC3T3–E1 cells. J Biol Chem 271:6411–6416

Saito M, Fujii K, Tanaka T, Soshi S (2004) Effect of low- and high-intensity pulsed ultrasound on collagen post-translational modifications in MC3T3–E1 osteoblasts. Calcif Tissue Int 75:384–395

Rodriguez C, Alcudia JF, Martinez-Gonzalez J et al (2008) Lysyl oxidase (LOX) down-regulation by TNFalpha: a new mechanism underlying TNFalpha-induced endothelial dysfunction. Atherosclerosis 196:558–564

Turecek C, Fratzl-Zelman N, Rumpler M (2008) Collagen cross-linking influences osteoblastic differentiation. Calcif Tissue Int 82:392–400

Fujii K, Kuboki Y, Sasaki S (1976) Aging of human bone and cartilage collagen: changes in the reducible cross-links and their precursors. Gerontology 22:363–370

Bailey AJ, Shimokomaki MS (1971) Age related changes in the reducible cross-links of collagen. FEBS Lett 16:86–88

Robins SP, Shimokomaki M, Bailey AJ (1973) Age-related changes in the reducible components of intact bovine collagen fibres. Biochem J 131:771–780

Ogawa T, Ono T, Tsuda M (1982) A novel fluor in insoluble collagen: a crosslinking moiety in collagen molecule. Biochem Biophys Res Commun 107:1252–1257

Eyre DR, Oguchi H (1980) The hydroxypyridinium crosslinks of skeletal collagens: their measurement, properties and a proposed pathway of formation. Biochem Biophys Res Commun 92:403–410

Robins SP, Duncan A (1983) Cross-linking of collagen. Location of pyridinoline in bovine articular cartilage at two sites of the molecule. Biochem J 215:175–182

Banse X, Sims TJ, Bailey AJ (2002) Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links. J Bone Miner Res 17:1621–1628

Brady JD, Robins SP (2001) Structural characterization of pyrrolic cross-links in collagen using a biotinylated Ehrlich’s reagent. J Biol Chem 276:18812–18818

Kuypers R, Tyler M, Kurth LB et al (1992) Identification of the loci of the collagen-associated Ehrlich chromogen in type I collagen confirms its role as a trivalent cross-link. Biochem J 283:129–136

Hanson DA, Eyre DR (1996) Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone. J Biol Chem 271:26508–26516

Banse X, Devogelaer JP, Lafosse A et al (1998) Cross-link profile of bone collagen correlates with structural organization of trabeculae. Bone 31:70–76

Knott L, Bailey AJ (1998) Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. Bone 22:181–187

Vashishth D (2007) The role of the collagen matrix in skeletal fragility. Curr Osteoporos Rep 5:62–66

Paul RG, Bailey AJ (1996) Glycation of collagen: the basis of its central role in the late complications of aging and diabetes. Int J Biochem Cell Biol 28:1297–1310

Hein G, Weiss C, Lehmann G et al (2005) Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis 65:101–104

Hernandez CJ, Tang SY, Baumbach BM et al (2005) Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. Bone 37:825–832

Viguet-Carrin S, Farlay D, Bala Y et al (2008) An in vitro model to test the contribution of advanced glycation end products to bone biomechanical properties. Bone 42:139–149

Wang X, Shen X, Li X et al (2002) Age-related changes in the collagen network and toughness of bone. Bone 31:1–7

Nakamura K, Nakazawa Y, Ienaga K (1997) Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. Biochem Biophys Res Commun 232:227–230

Sims TJ, Rasmussen LM, Oxlund H et al (1996) The role of glycation cross-links in diabetic vascular stiffening. Diabetologia 39:946–951

Takahashi M, Hoshino H, Kushida K et al (1995) Direct measurement of crosslinks, pyridinoline, deoxypyridinoline, and pentosidine, in the hydrolysate of tissues using high-performance liquid chromatography. Anal Biochem 232:158–162

Viguet-Carrin S, Gineyts E, Bertholon C (2009) Simple and sensitive method for quantification of fluorescent enzymatic mature and senescent crosslinks of collagen in bone hydrolysate using single-column high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 877:1–7

Bank RA, Beekman B, Verzijl N et al (1997) Sensitive fluorimetric quantitation of pyridinium and pentosidine crosslinks in biological samples in a single high-performance liquid chromatographic run. J Chromatogr B Biomed Sci Appl 703:37–44

Saito M, Fujii K, Mori Y et al (2006) Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int 17:1514–1523

Garnero P, Borel O, Gineyts E et al (2006) Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone 38:300–309

Saito M, Mori S, Mashiba T et al (2008) Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs. Osteoporos Int 19:1343–1354

Silva MJ, Brodt MD, Lynch MA et al (2009) Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth and diminished whole-bone strength and fatigue life. J Bone Miner Res 94:1618–1627

Viguet-Carrin S, Roux JP, Arlot ME et al (2006) Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone 39:1073–1079

Vashishth D, Gibson GJ, Khoury JI et al (2001) Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28:195–201

Biemel KM, Reihl O, Conrad J et al (2001) Formation pathways for lysine-arginine cross-links derived from hexoses and pentoses by Maillard processes: unraveling the structure of a pentosidine precursor. J Biol Chem 276:23405–23412

Sell DR, Biemel KM, Reihl O et al (2005) Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. J Biol Chem 280:12310–12315

Robins SP, Bailey AJ (1972) Age-related changes in collagen: the identification of reducible lysine-carbohydrate condensation products. Biochem Biophys Res Commun 48:76–84

Monnier VM, Sell DR, Dai Z et al (2008) The role of the amadori product in the complications of diabetes. Ann NY Acad Sci 1126:81–88

Brennan M (1989) Changes in solubility, non-enzymatic glycation, and fluorescence of collagen in tail tendons from diabetic rats. J Biol Chem 264:20947–20952

Saito M (1999) Age-related changes in biochemical characteristics of collagen from human weight-bearing and non-weight-bearing bone. Tokyo Jikeikai Ika Daigaku Zasshi 114:327–337 (in Japanese), http://sciencelinks.jp/j-east/article/200010/000020001000A0286989.php

Ogawa N, Yamaguchi T, Yano T et al (2007) The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3–E1 cells through glucose-induced increase in the receptor for AGEs. Horm Metab Res 39:871–875

Mercer N, Ahmed H, Etcheverry SB et al (2007) Regulation of advanced glycation end product (AGE) receptors and apoptosis by AGEs in osteoblast-like cells. Mol Cell Biochem 306:87–94

Cortizo AM, Lettieri MG, Barrio DA et al (2003) Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK). Mol Cell Biochem 250:1–10

Sanguineti R, Storace D, Monacelli F et al (2008) Pentosidine effects on human osteoblasts in vitro. Ann NY Acad Sci 1126:166–172

Miyata T, Notoya K, Yoshida K et al (1997) Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 8:260–270

Ding KH, Wang ZZ, Hamrick MW et al (2006) Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss. Biochem Biophys Res Commun 340:1091–1097

Valcourt U, Merle B, Gineyts E et al (2007) Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 282:5691–5703

Urena P, De Vernejoul MC (1999) Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 55:2141–2156

Allen MR, Gineyts E, Leeming DJ et al (2008) Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. Osteoporos Int 19:329–337

Tang SY, Allen MR, Phipps R et al (2008) Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int 94:887–894

Odetti P, Rossi S, Monacelli F et al (2005) Advanced glycation end products and bone loss during aging. Ann NY Acad Sci 1043:710–717

McCarthy AD, Etcheverry SB, Bruzzone L et al (2001) Non-enzymatic glycation of a type I collagen matrix: effect on osteoblastic development and oxidative stress. BMC Cell Biol 2:16

Saito M, Marumo K, Soshi S et al (2009) Raloxifene ameliorates detrimental enzymatic and non-enzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia. Osteoporos Int. doi: 10.1007/s00198-009-0980-4

Saito M, Fujii K, Soshi S et al (2006) Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int 17:986–995

Miyata T, van Ypersele de Strihou C et al (1999) Alterations in nonenzymatic biochemistry in uremia: origin and significance of “carbonyl stress” in long-term uremic complications. Kidney Int 55:389–399

LaCroix AZ, Lee JS, Wu L et al (2008) Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women. J Am Geriatr Soc 56:1434–1441

Knott L, Tarlton JF, Bailey AJ (1997) Chemistry of collagen cross-linking: biochemical changes in collagen during the partial mineralization of turkey leg tendon. Biochem J 322:535–542

Paschalis EP, Recker R, Dicarlo E et al (2003) Distribution of collagen cross-links in normal human trabecular bone. J Bone Miner Res 18:1942–1946

Paschalis EP, Shane E, Lyritis G et al (2004) Bone fragility and collagen cross-links. J Bone Miner Res 19:2000–2004

Mashiba T, Mori S, Burr DB et al (2005) The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib. J Bone Miner Metab 23(Suppl):36–42

Nyman JS, Roy A, Acuna RL et al (2006) Age-related effect on the concentration of collagen crosslinks in human osteonal and interstitial bone tissue. Bone 39:1210–1217

Gourion-Arsiquaud S, Burket J, Havill L et al (2009) Spatial variation in osteonal bone properties relative to tissue and animal age. J Bone Miner Res 24:1271–1281

Eyre DR (1981) Cross-link maturation in bone collagen. Dev Biochem 22:51–54

Wojtowicz A, Dziedzic-Goclawska A, Kaminski A et al (1997) Alteration of mineral crystallinity and collagen cross-linking of bones in osteopetrotic toothless (tl/tl) rats and their improvement after treatment with colony stimulating factor-1. Bone 20:127–132

Durchschlag E, Paschalis EP, Zoehrer R et al (2006) Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate. J Bone Miner Res 21:1581–1590

Otsubo K, Katz EP, Mechanic GL (1992) Cross-linking connectivity in bone collagen fibrils: the COOH-terminal locus of free aldehyde. Biochemistry 31:396–402

Oxlund H, Barckman M, Ortoft G et al (1995) Reduced concentrations of collagen cross-links are associated with reduced strength of bone. Bone 17:365S–371S

Knott L, Whitehead CC, Fleming RH et al (1995) Biochemical changes in the collagenous matrix of osteoporotic avian bone. Biochem J 310:1045–1051

Opsahl W, Zeronian H, Ellison M et al (1982) Role of copper in collagen cross-linking and its influence on selected mechanical properties of chick bone and tendon. J Nutr 112:708–716

Knott L, Bailey AJ (1999) Collagen biochemistry of avian bone: comparison of bone type and skeletal site. Br Poult Sci 40:371–379

Bailey AJ, Sims TJ, Ebbesen EN (1999) Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int 65:203–210

Shimazaki M, Nakamura K, Kii I et al (2008) Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 205:295–303

Mochida Y, Parisuthiman D, Pornprasertsuk-Damrongsri S et al (2009) Decorin modulates collagen matrix assembly and mineralization. Matrix Biol 28:44–52

Parisuthiman D, Mochida Y, Duarte WR et al (2005) Biglycan modulates osteoblast differentiation and matrix mineralization. J Bone Miner Res 20:1878–1886

Wallace JM, Golcuk K, Morris MD et al (2009) Inbred strain-specific response to biglycan deficiency in the cortical bone of C57BL6/129 and C3H/He mice. J Bone Miner Res 24:1002–1012

Tang SY, Zeenath U, Vashishth D (2007) Effects of non-enzymatic glycation on cancellous bone fragility. Bone 40:1144–1151

Nyman JS, Roy A, Tyler JH et al (2007) Age-related factors affecting the postyield energy dissipation of human cortical bone. J Orthop Res 25:646–655

Wang X, Qian C (2006) Prediction of microdamage formation using a mineral-collagen composite model of bone. J Biomech 39:595–602

Oxlund H, Mosekilde L, Ortoft G (1996) Reduced concentration of collagen reducible crosslinks in human trabecular bone with respect to age and osteoporosis. Bone 19:479–484

Bailey AJ, Wotton SF, Sims TJ et al (1993) Biochemical changes in the collagen of human osteoporotic bone matrix. Connect Tissue Res 29:119–132

Robins SP (1982) Analysis of the crosslinking components in collagen and elastin. Methods Biochem Anal 28:329–379

Avery NC, Sims TJ, Bailey AJ (2009) Quantitative determination of collagen cross-links. Methods Mol Biol 522:103–121

Biemel KM, Friedl DA, Lederer MO (2002) Identification and quantification of major maillard cross-links in human serum albumin and lens protein. Evidence for glucosepane as the dominant compound. J Biol Chem 277:24907–24915

Boskey AL, DiCarlo E, Paschalis E et al (2005) Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation. Osteoporos Int 16:2031–2038

Hara K, Kobayashi M, Akiyama Y (2007) Influence of bone osteocalcin levels on bone loss induced by ovariectomy in rats. J Bone Miner Metab 25:345–353

Boivin GY, Chavassieuv SAC et al (2000) Alendronate increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27:687–694

Grynpas MD, Hunter GK (1988) Bone mineral and glycosaminoglycans in newborn and mature rabbits. J Bone Miner Res 3:159–164

Zioupos P, Currey JD, Hamer AJ (1999) The role of collagen in the declining mechanical properties of aging human cortical bone. J Biomed Mater Res 45:108–116

Dequeker J, Merlevede W (1971) Collagen content and collagen extractability pattern of adult human trabecular bone according to age, sex and amount of bone mass. Biochim Biophys Acta 244:410–420

Danielsen CC (1990) Age-related thermal stability and susceptibility to proteolysis of rat bone collagen. Biochem J 272:697–701

van der Harst MR, DeGroot J, Kiers GH et al (2005) Biochemical analysis of the articular cartilage and subchondral and trabecular bone of the metacarpophalangeal joint of horses with early osteoarthritis. Am J Vet Res 66:1238–1246

Arnaud SB, Buckendahl P, Durnova G et al (2000) Bone biochemistry in rat femoral diaphysis after space flight. J Gravit Physiol 7:7–15

Silva MJ, Brodt MD, Wopenka B et al (2006) Decreased collagen organization and content are associated with reduced strength of demineralized and intact bone in the SAMP6 mouse. J Bone Miner Res 21:78–88

Saito M, Marumo K, Ushiku C, et al (2009) Weekly treatment with human parathyroid hormone (1-34) for 18 months increases bone strength via the amelioration of microarchitecture, degree of mineralization, enzymatic and non-enzymatic cross-link formation in ovariectomized cynomolgus monkeys. J Bone Miner Res Suppl FR0044

Bailey AJ, Knott L (1999) Molecular changes in bone collagen in osteoporosis and osteoarthritis in the elderly. Exp Gerontol 34:337–351

Gourion-Arsiquaud S, Faibish D, Myers E et al (2009) Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture. J Bone Miner Res 24:1565–1571

McLean RR, Hannan MT (2007) B vitamins, homocysteine, and bone disease: epidemiology and pathophysiology. Curr Osteoporos Rep 5:112–119

McKusick VA (1966) Heritable disorders of connective tissue, vol 3rd. C.V. Mosby, St Louis, p 155

Lubec B, Fang-Kircher S, Lubec T et al (1996) Evidence for McKusick’s hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 13:159–162

Eberhardt RT, Forgione MA, Cap A et al (2000) Endothelial dysfunction in a murine model of mild hyper homocyst(e)inemia. J Clin Invest 106:483–491

Herrmann M, Tami A, Wildemann B et al (2008) Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone 44:467–475

Brennan TC, Rizzoli R, Ammann P (2009) Selective modification of bone quality by PTH, pamidronate, or raloxifene. J Bone Miner Res 24:800–808

Hein G, Wiegand R, Lehmann G et al (2003) Advanced glycation end-products pentosidine and Nε-carboxymethyllysine are elevated in serum of patients with osteoporosis. Rheumatology 42:1242–1246

Koyama Y, Takeishi Y, Arimoto T et al (2007) High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure. J Card Fail 13:199–206

Kageyama Y, Takahashi M, Ichikawa T et al (2008) Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis. Clin Exp Rheumatol 26:73–80

Banfi G, Iorio EL, Corsi MM (2008) Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med 46:1550–1555

Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int 18:427–444

Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412

Tomasek JJ, Meyers SW, Basinger JB et al (1994) Diabetic and age-related enhancement of collagen-linked fluorescence in cortical bones of rats. Life Sci 55:855–861

Sugiyama S, Miyata T, Ueda Y et al (1998) Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J Am Soc Nephrol 9:1681–1688

Takahashi M, Ohishi T, Aoshima H et al (1993) The Maillard protein cross-link pentosidine in urine from diabetic patients. Diabetologia 36:664–667

Culbertson SM, Vassilenko EI, Morrison LD et al (2003) Paradoxical impact of antioxidants on post-Amadori glycoxidation: counterintuitive increase in the yields of pentosidine and nepsilon-carboxymethyllysine using a novel multifunctional pyridoxamine derivative. J Biol Chem 278:38384–38394

Saito M, Fujii K, Soshi S et al (2005) Effects of vitamin B6 and vitamin K2 on bone mechanical properties and collagen cross-links in spontaneously diabetic WBN/Kob rats. J Bone Miner Res Suppl SU420

Khatami M, Suldan Z, David I et al (1988) Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation. Life Sci 43:1725–1731